BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 12772793)

  • 1. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
    Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S
    Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.
    Kadokawa Y; Omagari K; Hazama H; Ohba K; Masuda J; Kinoshita H; Hayashida K; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
    Clin Biochem; 2003 May; 36(3):203-10. PubMed ID: 12726929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: applications of a routine diagnostic tool for the detection of antimitochondrial antibodies.
    Hazama H; Omagari K; Masuda J; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
    J Gastroenterol Hepatol; 2002 Mar; 17(3):316-23. PubMed ID: 11982703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
    Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
    Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis.
    Omagari K; Kadokawa Y; Nakamura M; Akazawa S; Ohba K; Ohnita K; Mizuta Y; Daikoku M; Yatsuhashi H; Ishibashi H; Kohno S
    Autoimmunity; 2006 Mar; 39(2):107-12. PubMed ID: 16698666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.
    Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME
    Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
    Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
    Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
    Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
    Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis.
    Hazama H; Omagari K; Masuda J; Kinoshita H; Ohba K; Sakimura K; Matsuo I; Isomoto H; Murase K; Murata I; Kohno S
    J Clin Lab Anal; 2000; 14(5):208-13. PubMed ID: 11018798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
    Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
    Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC.
    Fukushima N; Nalbandian G; Van De Water J; White K; Ansari AA; Leung P; Kenny T; Kamita SG; Hammock BD; Coppel RL; Stevenson F; Ishibashi H; Gershwin ME
    Hepatology; 2002 Dec; 36(6):1383-92. PubMed ID: 12447863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.
    Van de Water J; Turchany J; Leung PS; Lake J; Munoz S; Surh CD; Coppel R; Ansari A; Nakanuma Y; Gershwin ME
    J Clin Invest; 1993 Jun; 91(6):2653-64. PubMed ID: 8514873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to E1 and E2/Protein X components of pyruvate dehydrogenase complex in sera of patients with primary biliary cirrhosis.
    Kuroda M; Morito T; Takagi T; Ohira H; Kokubun M; Kojima T; Ono K; Kochi H; Kasukawa R
    J Hepatol; 1996 Dec; 25(6):867-76. PubMed ID: 9007715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY; Rowley MJ; Mackay IR
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetic analysis of a panel of monoclonal IgG and IgM anti-PDC-E2/X antibodies derived from patients with primary biliary cirrhosis.
    Thomson RK; Davis Z; Palmer JM; Arthur MJ; Yeaman SJ; Chapman CJ; Spellerberg MB; Stevenson FK
    J Hepatol; 1998 Apr; 28(4):582-94. PubMed ID: 9566826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.
    Tsuneyama K; Van de Water J; Leung PS; Cha S; Nakanuma Y; Kaplan M; De Lellis R; Coppel R; Ansari A; Gershwin ME
    Hepatology; 1995 Apr; 21(4):1031-7. PubMed ID: 7535733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis.
    Omagari K; Rowley MJ; Jois JA; Feeney SJ; Komatsu K; Maeda T; Onishi S; Yamazaki K; Suzuki K; Galperin C; Mackay IR
    J Gastroenterol; 1996 Feb; 31(1):61-8. PubMed ID: 8808430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.
    Ikuno N; Mackay IR; Jois J; Omagari K; Rowley MJ
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1390-4. PubMed ID: 11851838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes.
    Chen QY; Mackay IR; Fida S; Myers MA; Rowley MJ
    J Autoimmun; 1998 Apr; 11(2):151-61. PubMed ID: 9650094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.